AH Capital Management

Latest statistics and disclosures from a16z Capital Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are FIG, META, RVMD, OMDA, XYZ, and represent 93.39% of a16z Capital Management's stock portfolio.
  • Added to shares of these 2 stocks: FIG (+$843M), META (+$156M).
  • Started 2 new stock positions in META, FIG.
  • Reduced shares in these 1 stock: OPEN.
  • Sold out of its position in OPEN.
  • a16z Capital Management was a net buyer of stock by $996M.
  • a16z Capital Management has $1.4B in assets under management (AUM), dropping by 345.78%.
  • Central Index Key (CIK): 0001540358

Tip: Access up to 7 years of quarterly data

Positions held by AH Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for a16z Capital Management

a16z Capital Management holds 11 positions in its portfolio as reported in the September 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Figma Class A Com Stk (FIG) 60.4 $843M NEW 16M 51.87
 View chart
Meta Platforms Cl A (META) 11.2 $156M NEW 213k 734.38
 View chart
Revolution Medicines (RVMD) 9.2 $128M 2.7M 46.70
 View chart
Omada Health (OMDA) 7.3 $102M 4.6M 22.11
 View chart
Block Cl A (XYZ) 5.3 $74M 1.0M 72.27
 View chart
Maze Therapeatics (MAZE) 3.2 $44M 1.7M 25.93
 View chart
Bioage Labs (BIOA) 1.4 $19M 3.2M 5.88
 View chart
Nautilus Biotechnology (NAUT) 1.1 $15M 18M 0.84
 View chart
Camp4 Therapeutics Corp (CAMP) 0.5 $6.4M 2.1M 3.00
 View chart
Erasca (ERAS) 0.4 $6.2M 2.9M 2.18
 View chart
Ginkgo Bioworks Holdings Cl A New (DNA) 0.1 $1.6M 109k 14.58
 View chart

Past Filings by a16z Capital Management

SEC 13F filings are viewable for a16z Capital Management going back to 2023